Neng Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Biomaterials top 1%
- Advanced Cellulose Research Studies
Papers in
-
- Bioactive Natural Diterpenoids Research 6
- Wnt/β-catenin signaling in development and cancer 5
- Epidemiology 14
- Autophagy in Disease and Therapy 7
- Co-authors
- Zhiyu Wang (54 shared papers)Rongshi Cheng (4 shared papers)Enyong Ding (4 shared papers)Shengqi Wang (38 shared papers)Yifeng Zheng (36 shared papers)Fengxue Zhang (15 shared papers)Xuan Wang (11 shared papers)Bowen Yang (13 shared papers)
- Journals
- Oncotarget (6 papers)Frontiers in Pharmacology (6 papers)Cell Death and Disease (5 papers)Phytomedicine (5 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Neng Wang
129 papers receiving 5.9k citations
Neng Wang's Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 851
- Biomaterials 740
- Pharmacology 457
- Hepatology 295
- Oncology 903
Countries citing papers authored by Neng Wang
This map shows the geographic impact of Neng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neng Wang more than expected).
Fields of papers citing papers by Neng Wang
This network shows the impact of papers produced by Neng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neng Wang. The network helps show where Neng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Neng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Thermal degradation behaviors of spherical cellulose nanocrystals with sulfate groups Hit paper breakdown → | 2007 | 531 |
| 2 | Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients Hit paper breakdown → | 2020 | 306 |
| 3 | 2018 | 246 | |
| 4 | 2015 | 232 | |
| 5 | 2020 | 215 | |
| 6 | 2013 | 203 | |
| 7 | 2014 | 198 | |
| 8 | 2012 | 178 | |
| 9 | 2012 | 139 | |
| 10 | 2011 | 139 | |
| 11 | 2015 | 136 | |
| 12 | 2007 | 123 | |
| 13 | 2013 | 122 | |
| 14 | 2018 | 106 | |
| 15 | 2018 | 104 | |
| 16 | 2014 | 98 | |
| 17 | 2019 | 95 | |
| 18 | 2021 | 93 | |
| 19 | 2019 | 92 | |
| 20 | 2016 | 91 |
About Neng Wang
Neng Wang is a scholar working on Molecular Biology, Epidemiology, Cell Biology, Oncology and Immunology, having authored 139 papers that have together received 6.0k indexed citations. Recurring topics across this work include Caveolin-1 and cellular processes (9 papers), Immune cells in cancer (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Autophagy in Disease and Therapy (7 papers), Bioactive Natural Diterpenoids Research (6 papers), Cancer Cells and Metastasis (5 papers), Marine Sponges and Natural Products (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). The work is most often cited by research in Cancer Research (851 citations), Biomaterials (740 citations), Pharmacology (457 citations), Hepatology (295 citations) and Oncology (903 citations). Neng Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Zhiyu Wang, Rongshi Cheng, Enyong Ding, Shengqi Wang, Yifeng Zheng, Fengxue Zhang, Xuan Wang, Bowen Yang, Yi Lin and Xiaoming Xie. Their work appears in journals such as Oncotarget, Frontiers in Pharmacology, Cell Death and Disease, Phytomedicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.